Contract Research Organization specializing in a variety of clinical trial solutions such as trial development and management.

Second quarter 2009 earnings release, webcast and conference call announced by PPD.
(1 July 09)

PPD confirms Takeda receives FDA complete response for alogliptin.
(29 June 09)

Additional Phase III Priligy® studies confirmed by PPD.
(10 June 09)

PPD announces Takeda to conduct additional study for alogliptin MAA in the EU.
(3 June 09)

Proven global CRO leader with approximately 10,500 professionals in 43 countries offering clinical trial solutions.

Strong track record of partnering with pharmaceutical, biotechnology and medical device companies.

Expertise in clinical trial product development and life cycle management to maximize clients' investments.

Therapeutic leadership for more than 20 years.

Contact us to learn more.